Leading medical experts are calling for a shift toward routine cancer screening in India's healthcare strategy to replace the current reliance on symptom-driven diagnostic approaches.
Mahajan Imaging & Labs reported a 32% increase in cancer-related diagnostic investigations across Delhi-NCR centres between June 2025 and June 2026, signaling rising public awareness.
Data shows significant growth in preventive testing uptake, with prostate-specific antigen tests rising by 280%, Pap smears by 83%, and mammography examinations by 26% over the past year.